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Abstract
Some strains of mouse hepatitis virus (MHV) can induce chronic inflammatory
demyelination in mice that mimics certain pathological features of multiple sclerosis
(MS). We have examined neural cell tropism of demyelinating and nondemyelinating strains of mouse hepatitis virus in order to determine whether
central nervous system (CNS) cell tropism plays a role in demyelination. Previous
studies demonstrated that recombinant MHV strains, isogenic other than for the
spike gene differ in the extent of neurovirulence and the ability to induce
demyelination. Here we demonstrate that these strains also differ in their ability to
infect particular cell type(s) in the brain.

Furthermore, there is a correlation

between the differential localization of viral antigen in spinal cord gray matter
versus white matter during acute infection and the ability to induce demyelination
later on. Viral antigen from demyelinating strains is detected initially in both gray
and white matter, with subsequent localization to white matter of the spinal cord,
whereas viral antigen localization of non-demyelinating strains is mainly restricted
to gray matter. This suggests that the localization of viral antigen to white matter
during the acute stage of infection is essential for induction of chronic
demyelination. Overall, these observations suggest that isogenic demyelinating
and non-demyelinating strains of MHV, differing in the spike protein expressed,
infect neurons versus glial cells in different proportions and that differential tropism
to a particular CNS cell type may play a significant role in mediating the onset and
mechanisms of demyelination.

Introduction
Multiple

sclerosis

(MS)

is

a

common

disabling

neurological

disease,

pathologically characterized by demyelination, loss of oligodendroglial cells, and
axonal degeneration (25, 26). The mechanisms that culminate in the destruction
of oligodendrocytes and loss of central nervous system (CNS) myelin are not well
understood. The process is believed to involve a T-cell mediated autoimmune
phenomenon that may be triggered by one or more viral infections (1). Several
experimental viral model systems have been instrumental in providing these
insights (2). One of the animal models is based on mouse hepatitis virus (MHV)induced demyelination in mice that mimics the pathology of MS (12, 19, 21, 39,
42). Infection with neurotropic MHV strains produces a bi-phasic neurological
disease with acute meningoencephalitis preceding the onset of chronic
demyelination (21).

Following intracranial inoculation (i.c.), MHV is first observed in the brain and
subsequently spreads into the spinal cord (30). Viral titer reaches its peak at
approximately day 5 post-infection. Infectious viral particles are cleared within
the first 7 to 10 days after infection, although viral RNA persists in the white
matter of the spinal cord for several months (20, 29). Viral RNA persistence has
been demonstrated in spinal cords of mice infected with demyelinating strains of
MHV, including MHV-A59 and JHM (17, 20, 29), and has been suggested to be a
prerequisite for MHV-induced demyelination. Indeed, MHV-2 and Penn97-1(a
non demyelinating recombinant strain of MHV) (3), which do not persist, also do

not cause demyelination (4). Interestingly, the viral RNA of SMHV2-RA59, a
chimeric strain (non-demyelinating strain of MHV, expressing MHV-2 spike gene
in the MHV-A59 background, previously called Penn 98-1/2) persists in the spinal
cord during chronic infection, and yet is unable to induce demyelination (4),
indicating that viral RNA persistence in the spinal cord per se is insufficient to
induce chronic demyelination. Genes for the spike protein, which are known to
mediate viral entry, if exchanged between strains may alter the capacity of MHV
to infect and replicate in particular CNS cell types (neurons, astrocytes, microglia
and oligodendrocytes) during the acute stage of infection, and therefore influence
the induction of chronic demyelination.

Little is known about the involvement of CNS cell tropism in MHV-induced
demyelination. It is known, however, that in the CNS, demyelinating MHVs
infect

a

variety

of

neural

cell

types,

including

neurons,

astrocytes,

oligodendrocytes, microglia, and ependymal cells (15, 19, 21, 43). Recently by
using JHM spike chimeric viruses, Phillips et al. (32) demonstrated that spike
gene-mediated neurovirulence of MHV is associated with extensive viral spread
in the brain in both neurons and astrocytes. However, no studies have examined
whether non-demyelinating MHV strains infect the same CNS cell types as
demyelinating strains.

We have examined CNS cell tropism of both demyelinating and nondemyelinating MHV strains during the acute stage of infection, in order to

determine how the infection of a particular cell type(s) influences the likelihood of
development of chronic demyelination.

This entailed asking whether non-

demyelinating strains differ in their ability to infect gray and white matter cells in
the spinal cord during acute infection.
We have used recombinant MHVs: SJHM-RA59EGFP (highly neurovirulent and
demyelinating), RA59EGFP (weakly neurovirulent but demyelinating)(38), and
SMHV2-RA59EGFP (neurotropic but non-demyelinating)(33).

All three viruses

express enhanced green fluorescent protein (EGFP) and are isogenic, except for
the spike gene, and differ in their neurovirulence and demyelination properties.

During acute infection these three isogenic recombinant MHVs differ in spread
and also in their CNS cell tropism.

Most interestingly, viral antigen of the

demyelinating strains is first detected in gray matter, with subsequent localization
to white matter; while antigen of non-demyelinating strains is mainly restricted to
gray matter with occasional distribution to white matter. The distribution of viral
antigen in white matter during the acute stage of infection may be one of the key
factors in chronic viral persistence and induction of demyelination.

Materials and Methods
Viruses and cells: EGFP expressing recombinant viruses SJHM-RA59EGFP and
RA59EGFP are isogenic except that SJHM-RA59EGFP expresses the JHM spike gene
and RA59EGFP carries the MHV-A59 spike gene (38). These two EGFP expressing

viruses were generated from our previous studies (38) where they were named
SJHM-REGFP and SA59-REGFP for SJHM-RA59EGFP and RA59EGFP, respectively.
Construction of SMHV2-RA59EGFP: To construct a non demyelinating EGFP
tagged isogenic recombinant strain SMHV2-RA59EGFP, the MHV-2 ( a non
demyelinating MHV strain)(3) spike gene was cleaved from pMH54-SMHV2EGFP
with AvrII and SbfI restriction digestion and inserted into the pMH54EGFP in place
of the A59 spike gene (4). Targeted RNA recombination was carried out as
described in our previous published work (38). For each desired recombinant, at
least two strains derived from independent recombination events were
characterized.

EGFP expressing viruses with the MHV-2 spike gene were

labeled as SMHV2-RA59EGFP.

We previously used this recombinant EGFP

tagged strain of SMHV2-RA59 in our other studies (33).
Inoculation of mice: Four-week-old, MHV-free C57Bl/6 (B6) male mice
(National Cancer Institute, Frederick, MD) were used in all experiments. Mice
were anesthetized with isoflurane (IsoFlo; Abbott Laboratories, North Chicago,
IL) prior to inoculation. For intracranial inoculations, 20 µl of diluted virus (in PBS
containing 0.75% bovine serum albumin) were injected into the left cerebral
hemisphere. Mock-infected controls were inoculated similarly but with an
uninfected 17Cl-1 cell lysate at a comparable dilution.

All experimental

procedures were approved by the Institutional Animal Care and Use Committee.
Virulence and viral titers in mice: Virulence was assayed by calculating the
lethal dose (LD50). Mice were inoculated intracranially with 10-fold serial dilutions
of viruses (five mice per dilution). Signs of disease or death were monitored on a

daily basis up to 30 days post infection. LD(50) values were calculated by the
Reed-Muench method (34). For measurement of viral titers in the liver and the
brain, mice were sacrificed at 1, 3, 5, 7, 9 and 11 days post infection and
perfused with 2 ml of sterile PBS. Brains and livers were removed aseptically
and separately placed directly into 5 ml of isotonic saline with 0.167% gelatin (gel
saline). All organs were weighed and stored frozen at -80 ºC. Brains and livers
were homogenized, and viral titers were determined by plaque assay on L2 cell
monolayers (4).
Histopathological analysis:

For analysis of organ pathology, mice were

infected intracranially, sacrificed at various times (day 3, 5, 7 and 10 post
infection), and perfused with 5 ml of saline followed by 10% phosphate-buffered
formalin. Brains and spinal cords were removed and tissues were embedded in
paraffin and sectioned for staining. Brain and spinal cord sections were stained
with hematoxylin and eosin (H&E) and used for pathological evaluations by light
microscopy.

For assessment of demyelination, mice were inoculated

intracranially with 0.5 LD (50) dose (8 mice per virus strain) and sacrificed at day
30 post infection. Spinal cord sections were stained with Luxol fast blue to detect
plaques of demyelination. We repeated the demyelination experiment five times
with 8 mice in each group.

Demyelination was quantified by examining four

quadrants from two different levels of spinal cord sections for each mouse; thus
approximately eighty quadrants were examined for each virus. All slides were
coded and read in a blinded fashion (4).

Immunohistochemical analysis: Immunohistochemical analysis was performed
by

the

avidin-biotin-immunoperoxidase

technique

(Vector

Laboratories,

Burlington, CA) using 3,3’ diaminobenzidine as substrate, and a 1:20 dilution of
monoclonal antibody (MAb) directed against the nucleocapsid protein (N) of
MHV-JHM (Mab clone 1-16-1, kindly provided by Dr. Julian Leibowitz). Control
slides from mock-infected mice were incubated in parallel. All slides were read in
a blinded manner.

Immunofluorescence: Mice were inoculated intracranially and sacrificed (5 mice
per group) at days 3, 5, 7 post-infection.

Infected mice were perfused

transcardially with PBS followed by cold PBS containing 4% paraformaldehyde
and finally with 10 ml of PBS containing 10% sucrose. Brains were removed and
placed at 4 °C for 4 h in 10% sucrose and followed by 30% sucrose overnight.
Tissues were embedded in OCT medium (Tissue Tek, Hatfield, PA), sectioned
sagitally with a microtome to 6 µm thickness and mounted on glass slides. Some
sections were stained with H&E while others were left unstained for EGFP
detection and immunofluorescence.

To detect EGFP fluorescence without

immunostaining, frozen brain sections were fixed in ice-cold 95% ethanol for 20
min, incubated at room temperature in ice-cold PBS for 10 min, and then
mounted in 4.8% MOWIOL in 50% glycerol. Sections were visualized using an
Olympus X-70 microscope system with a 10X long-working distance UPlanF1
phase objective and a filter pack suitable for green fluorescence (UMWIBABP460-490 DM505 BA515-550).

We repeated the acute stage cell

tropism experiment with 5 mice in each group at 0.5 LD50 dose and repeated the
experiment 3 times. We also infected groups of 5 at 500 PFUs and 1000 PFUs
and obtained similar results in terms of cellular tropism. This experiment was
repeated twice.

Double label immunofluorescence: Frozen tissue sections were washed with
PBS at room temperature in a humidified chamber, incubated for 10 min at room
temperature with 1 mg/ml NaBH4 in PBS to reduce auto fluorescence, washed,
incubated for 1 h at room temperature with 1 M glycine in PBS to reduce
nonspecific cross linking, then washed subsequently with PBS, PBS + 0.5%
Triton X-100 (TX) and PBS + TX + 2% goat serum (GS). The sections were
incubated overnight at 4ºC with a primary antiserum diluted in PBS+TX+GS,
washed and then incubated with a secondary antiserum diluted into PBS+GS for
2 h at room temperature.

All incubations were carried out in a humidified

chamber. Viral antigen was detected by EGFP in FITC channel (38). Neurons
were identified with a 1:50 dilution of mouse monoclonal antibody AP14(10),
which recognizes the MAP2b protein (5, 36) (gift from Dr. Virginia M.-Y. Lee,
University of Pennsylvania, PA). Astrocytes were identified with a 1:100 dilution
of a rabbit anti-cow glial fibrillary acidic protein (GFAP) (Dako Corp. Carpinteria,
CA). Secondary antibodies were 1:100 dilution of Texas red conjugated goat anti
mouse IgG or anti rabbit IgG (Jackson Immune Research, West Grove, PA).
Control slides were incubated in parallel with pre-immune rabbit sera, and
sections from mock-infected mice were incubated with secondary antibodies

only.

Tissue sections were sequentially washed with PBS+TX and PBS,

mounted and visualized by fluorescence microscopy with a 40XUPlanApo oil
immersion objective, with the iris diaphragm partially closed to limit the
contribution of out-of-plane fluorescence, and with filter packs suitable for green
fluorescence (U-MWIBA BP460-490 DM505 BA515-550) and red fluorescence
(U-MNG BP530-550 DM570 BA590-800+).

Images were acquired with a

Hamamatsu Orca-1 CCD camera and Image pro image analysis software (Media
Cybernetics, Silver Spring, MD).

Results
Comparative
strains:

pathogenesis

of

demyelinating

and

non-demyelinating

We have compared the pathogenesis of SJHM-RA59EGFP, RA59EGFP

and SMHV2-RA59EGFP, which are isogenic except for the spike gene (Fig 1). We
used half of an LD

(50)

(0.5LD50) for these pathogenesis studies; this dose for

SJHM-RA59EGFP = 5,000 PFUs, for RA59EGFP = 20,000 and SMHV2RA59EGFP=100 PFUs.

We infected 8 mice in each group and repeated the

experiment 5 times altogether. Out of a total of 40 mice infected for each group,
26 mice survived in the SJHM-RA59EGFP infected group, 30 mice survived in the
RA59EGFP infected group and 24 mice survived in the SMHV2-RA59EGFP infected
group at day 30 post infection. Brain and spinal cord sections from mice infected
intracranially with SJHM-RA59EGFP, RA59EGFP and SMHV2-RA59EGFP were

stained either with H&E or Luxol fast blue and analyzed by light microscopy. No
demyelination was observed in any of the SMHV2-RA59EGFP (60% survival rate)
infected mice

(Fig. 2 Upper Panel), similar to its parental recombinant virus

SMHV2-RA59 (previously called Penn 98-1/2)(4). In contrast, demyelination was
observed in 100% of the RA59EGFP mice and 60% of the SJHM-RA59EGFP mice
(> 70 % survival rate) (Fig. 2, Upper Panel). This confirms our previous findings
that the spike gene determines the demyelination property of MHV.

In order to ensure that the non-demyelinating property of SMHV2-RA59EGFP is
not due to its inability to replicate in the host, we carried out intracranial
inoculations at 0.5
LD

(50)

dose of two independently isolated clones of SMHV2-RA59EGFP and

measured virus replication in mouse brain and liver as a function of time postinfection. The kinetics of viral replication and the final titers of viruses were
similar, albeit slightly lower (10-fold), for the EGFP-expressing viruses compared
to wild type recombinant virus. The peak of replication was observed at day 5,
similar to previous studies (4, 31)(data not shown).

Histopathological studies during acute phase of the infection revealed that all
three viruses produced meningoencephalitis.

Brain pathology consisted of

encephalitis, characterized by parenchymal lymphocytic infiltrates and microglial
nodules with focal neuronophagia (Fig 2, Middle Panel). The parenchymal

inflammation was more severe in SJHM-RA59EGFP infected mice brains than in
RA59EGFP and SMHV2-RA59EGFP, and brain sections from RA59EGFP showed
comparatively more parenchymal inflammation compared to SMHV2-RA59EGFP.
Associated lymphocytic meningitis was also present in all three strains (Fig 2,
Lower Panel). Pathogenic properties of these viruses are summarized in Table
1.

Liver pathology consisted of moderate to severe hepatitis following RA59EGFP
and SMHV2-RA59EGFP infection, similar to the respective parental recombinant
strains (28). The infection is characterized by multiple foci of necrosis throughout
the liver (data not shown). We did not observe any liver pathology in SJHMRA59EGFP virus infected mice.

Individual strains exhibit different cellular tropism: To compare the cellular
tropism of demyelinating versus non-demyelinating MHV strains, we performed
double label immunofluorescence on sagittal brain sections.

Mice were

inoculated intracranially with 0.5 LD (50) dose of SJHM-RA59EGFP, RA59EGFP and
SMHV2-RA59EGFP.

Infected animals were sacrificed at days 3 and 5 post-

infection and frozen sections were made.

EGFP fluorescence was used to

detect viral antigen positive cells, and immunofluorescent staining was carried
out using MAP2b as a neuron specific marker, and GFAP as an astrocyte
specific marker.

Sections were systematically scanned in a blinded fashion.

Representative pictures of dual color fluorescence of viral antigen plus MAP2b

and viral antigen plus GFAP are shown in Fig. 3 and 4, respectively. Visual
microscopic observations show that SJHM-RA59EGFP infects neurons more than
the other two strains.

On the contrary, in SJHM-RA9EGFP infected mice only a

very small number of viral antigen positive cells were also positive for the
astrocytic marker GFAP, whereas in RA59EGFP infected mice, EGFP positive cells
partially overlapped with GFAP staining. It appears there are other CNS cells
which are infected by RA59EGFP that are not astrocytes. More surprisingly, in
SMHV2-RA59EGFP infected mice EGFP positive cells were in complete overlap
with GFAP, demonstrating that most infected cells were astrocytes.

Thus,

SJHM-RA59EGFP is predominantly neuron tropic but may be less able to infect
astrocytes. RA59EGFP is multitropic and infects neurons as well as astrocytes and
also other cell types in the CNS; SMHV2-RA59EGFP infects astrocytes mainly, and
neurons with markedly reduced efficiency.

To avoid a high percentage of

mortality at high virus dose and simultaneously to produce an optimal level of
viral replication that does not damage the tissue to a degree that makes
microscopic observation unsuitable, we chose a 0.5 LD50 dose. However, to
ensure that viral tropism of virus during the acute stage of infection does not
depend on the dose, we also performed experiments which demonstrate that the
cellular tropism of SMHV2-RA59EGFP at 500 PFUs and 1000 PFUs at day 5 was
similar to that at 100 PFU. We also carried out infections with 500 PFUs and
1000 PFUs of SJHM-RA59EGFP and RA59EGFP and observed the same CNS cell
tropism as at higher dose, only with fewer infected cells.

Demyelinating and non-demyelinating strains differ in their viral antigen
localization in gray and white matter of the spinal cord. To examine whether
demyelinating and non-demyelinating strains differ in viral antigen distribution in
spinal cord gray and white matter, we collected spinal cord tissues from SJHMRA59EGFP, RA59EGFP and SMHV2-RA59EGFP infected mice at days 5 and 7 postinfection. Cross sections from several regions of all spinal cords were stained
with viral anti nucleocapsid antiserum. 10 mice were sacrificed per time point
following infection by a particular viral strain.

At day 5 post-infection viral

antigens were mainly observed in the gray matter of the spinal cord for all three
strains, but in SJHM-RA59EGFP and RA59EGFP infected mice some viral antigen
was also detected in the white matter (Fig. 5, Upper Panel). At day 7, most of
the viral antigen in SJHM-RA59EGFP and RA59EGFP was found in white matter,
whereas SMHV2-RA59EGFP viral antigen remained mainly restricted to gray
matter with occasional distribution to white matter (Fig. 5, Middle Panel).

In

SMHV2-RA59EGFP infected mice, viral antigen was occasionally observed in the
white matter (3 of 60 spinal cord sections), and in some spinal cord sections of
SMHV2-RA59EGFP viral antigen was detected at the gray- white matter junction
as shown in Fig 5, Lower Panel. We repeated the experiment three times with 10
mice in each group and we observed similar viral antigen distribution all three
experiments.
Discussion
The current studies highlight the important role of neural cell tropism of viral
antigen in MHV-induced demyelination in the CNS. Localization studies showed

that MHV strains that differ in their neurovirulence and ability to demyelinate also
differ in their ability to infect particular CNS cell types. SJHM-RA59EGFP infects
neurons with greater efficiency, and infection may spread more rapidly than
RA59EGFP, while SMHV2-RA59EGFP infects neurons with limited efficiency. This is
consistent with previous findings (32) that the degree of neurovirulence is not
only dependent on neuronal tropism but also on the number of infected neurons
and spread of the infection through neurites.

Evidence from closely related

strains of neurotropic viruses including HIV, TMEV and reovirus supports the
hypothesis that CNS cell tropism and spread in CNS cells play a major role in the
distribution and type of CNS lesions (18, 41, 45). Studies with LCMV and HIV
also suggest that virus strains that exhibit rapid spread are associated with
increased immune-mediated pathology (27, 44).

Recently, it has been

demonstrated that MHV spread to the spinal cord white matter occurs very
rapidly and protection from demyelination can be achieved by inhibiting this viral
spread during the acute phase of infection by recruiting high numbers of MHV
specific CD8+T cells (23).
Our study highlights the diverse modes of infection that may lead to
demyelination. In our study the non-demyelinating strain is less able to infect
neurons and spread through neurons; on the other hand, demyelinating strains
are highly neuron tropic and spread rapidly through neurites. In contrast, it has
been observed that a temperature-sensitive demyelinating mutant of JHM infects
mainly non-neuronal cells, having a strong tropism specifically for astrocytes, and
causes white matter lesions (11, 16). Similarly, it has been demonstrated that a

monoclonal antibody selected JHM variant, a spike protein mutant, infects the
glial cells predominantly in the CNS, causing subacute demyelination (8, 9).
Interestingly, the neurotropic and non-demyelinating MHV3 strain, which has an
in vitro tropism for neurons, ependymal cells, and meningial cells but not for
astrocytes and oligodendrocytes, can induce an initial ependymitis, meningitis,
and encephalitis in the absence of white matter lesions (40). Our in vivo data
demonstrate that the highly neurovirulent strain SJHM-RA59EGFP has very little
tropism for astrocytes. RA59EGFP and SMHV2-RA59EGFP infect astrocytes with
similar efficiency.

As demyelinating and non-demyelinating strains produce

similar infections in astrocytes, it appears that astrocytic infection during the
acute stage alone may not determine the onset of demyelination.

Our

observations suggest that astrocyte tropism may be a relevant factor in persistent
infection but direct astrocytic infection alone may not be sufficient to induce
demyelination.

The development of chronic demyelination involves replication and spread of
viral antigen in the spinal cord during the acute stage of infection and the
persistence of viral RNA in white matter. This is substantiated by our
observations on viral spread of non-demyelinating MHV in the spinal cord, where
viral antigen during the acute phase of infection is mainly restricted to gray
matter. In contrast, viral antigen from demyelinating strains spreads from gray to
white matter during the acute stage of infection. Specifically, after intracranial
infection and replication, viral antigens from the demyelinating strains SJHM-

RA59EGFP and RA59EGFP are mostly seen in spinal cord gray matter at day 5 post
infection and then in the white matter at day 7 post infection.

Our results

establish that demyelinating and non-demyelinating strains differ in their viral
antigen distribution in gray matter and white matter during acute infection. Viral
persistence observed previously in SMHV2-RA59 infected mouse spinal cord
during the chronic phase of infection may be due to the presence of viral RNA in
gray matter (4). Viral RNA for demyelinating strains is known to persist mainly in
the white matter (29). Due to lack of viral RNA persistence in the white matter,
essential for the induction of demyelination during chronic infection, SMHV2RA59 is unable to induce demyelination. It is possible that cell-specific viral RNA
persistence is necessary for demyelination.

These combined observations

reinforce the importance of glial cell infection in the onset of demyelination.

It can also be argued that the spread of viral antigen from neuron to neuron and
from neuron to glial cells plays a critical role in the induction of chronic stage
demyelination. Although there are no experimental data to demonstrate this, it
can be suggested, based on our current neural cell tropism studies, that
neuroinvasion by MHV may require entry into the nerve endings, transport to the
cell body, replication in the cell body, axonal transport to the synapse and
transneuronal viral spread. Similar mechanisms of axonal transport of virus
particles have been observed for the alpha herpesviruses, Herpes simplex virus
and pseudorabies virus (6, 7). Furthermore, Theiler’s murine encephalitis virus
(TMEV), a non-enveloped virus that, like MHV, causes chronic demyelination in

mice, is able to traffic from the axon into the surrounding myelin in the absence of
cell lysis (37). Thus, by a mechanism involving transneuronal spread, MHV may
gain access to synaptically linked neuronal circuits and glial cells. It is not clear
however, which type(s) of glial cells must be infected in order to promote the
development of MHV-induced chronic demyelinating disease.

Our studies focused mainly on neurons and astrocytes, as they represent the
majority of infected cells during the acute stage of MHV infection, but we cannot
disregard oligodendrocytes. It has been previously demonstrated that MHV can
infect oligodendrocytes (22), but the direct cytolytic effect of MHV on
oligodendrocytes is unclear (13, 14). Direct viral infection of oligodendrocytes
may contribute to MHV-induced demyelination, as observed in another human
demyelinating disease, progressive multifocal leukoencephalopathy (PML), which
is caused by JC virus infection of oligodendrocytes (24, 35). Experiments are
underway to optimize techniques that will facilitate detection of oligodendrocytes
in MHV infected tissues.

In summary, combined assessment of brain and spinal cord infections allows us
to infer an indirect role of neuronal cell tropism in demyelination. SJHM-RA59EGFP
and RA59EGFP infection can both spread from gray matter to white matter and
induce demyelination.

The inability of the non-demyelinating strain of MHV,

SMHV2-RA59EGFP, to spread from gray matter to white matter cells in the spinal
cord may be due to its inefficient spread through neurites.

Acute stage

inflammation and chronic stage demyelination may be two independent
phenomena; however, acute stage neuronal infection and the lack of viral spread
from neuronal to glial cells are likely key elements in the induction of
demyelination.
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Fig. 1. EGFP tagged isogenic recombinant viruses differ in the spike gene.
A schematic diagram of the MHV genome expressing EGFP replacing of gene 4a
and part of gene 4b.

SJHM-RA59EGFP expressing the JHM spike; RA59EGFP

expressing A59 spike gene and SMHV2-RA59EGFP in the background of A59
gene. All three recombinant viruses derived are isogenic, differing only in the
spike gene.

Fig. 2. CNS pathology of EGFP expressing MHVs.

Upper Panel.

Demyelination: Luxol fast blue stained spinal cord sections of mice infected with
SJHM-RA59EGFP, RA59EGFP or SMHV2-RA59EGFP, at day 30 post-infection. Thin
arrows indicate a region of demyelination, and the arrowheads indicate normal
myelinated area of white matter. Original magnifications 20X.

Middle Panel. Encephalitis; microglial nodules: Hematoxylin- and Eosin-stained
sections from the basal forebrain of mice infected with EGFP tagged MHVs at
day 7 post-infection.

Arrows indicate the microglial nodules (microglia with

elongated nuclei) and lymphocytes in the vicinity of neurons in mice infected with
SJHM-RA59EGFP, RA59EGFP and SMHV2-RA59EGFP.

Original magnifications

200X.

Lower Panel. Meningitis.

Hematoxylin- and eosin-stained sections from the

basal forebrain of mice infected with EGFP tagged MHVs at day 7 post-infection:

SJHM-RA59EGFP, RA59EGFP and SMHV2-RA59EGFP. In all cases, there is a brisk
leptomeningeal lymphocytic inflammatory infiltrate. Original magnifications 200X.
Fig. 3. Identification of EGFP MHV-infected neurons in the brain at day 5 postinfection. Mice were infected intracranially with SJHM-RA59EGFP, RA59EGFP and
SMHV2-RA59EGFP. Infected mice were sacrificed at day 5 post-infection, and the
brains were processed, sectioned and then labeled with anti MAP2b as primary- and
with Texas red goat anti-mouse IgG as secondary- antibodies. EGFP fluorescence
(green) was used to detect viral antigen- positive cells in the basal forebrain. Red
fluorescence shows the corresponding labeling of MAP2b in neurons.

Merged

images show colocalization of MAP2b and EGFP positive cells. Arrows identify cells
double positive for viral antigen and MAP2b. Bar= 250 microns.

Fig. 4. Colocalization of EGFP positive cells with astrocyte marker at day 5
post-infection.

Mice were infected intracranially with SJHM-RA59EGFP,

RA59EGFP and SMHV2-RA59EGFP. Infected mice were sacrificed at day 5 postinfection; brains were processed, sectioned and then immune labeled with anti
GFAP (astrocytic marker) antiserum, then stained with Texas red goat antimouse IgG as secondary antibodies. EGFP fluorescence was used to detect
viral antigen positive cells; red fluorescence was used to detect GFAP in
astrocytes. Merged images show colocalization of GFAP and EGFP positive
cells. Arrows identify cells double positive for viral antigen and GFAP. Bar= 250
microns.

Fig.5. Viral antigen expression in spinal cord sections of mice infected with
EGFP- expressing viruses.

Mice were inoculated intracranially with SJHM-

RA59EGFP, RA59EGFP and SMHV2-RA59EGFP. Mice were sacrificed at days 5 and
7 post-infection, spinal cord sections were stained with anti nucleocapsid
antiserum. Representative hemi-sections and complete sections of spinal cords
are shown from the cervical region of the spinal cord of day 5 (Upper Panel) and
day 7 (Middle Panel) infected mice. In SMHV2-RA59EGFP infected mice
occasional viral antigen distribution in the white matter and gray-white matter
junction is shown in Lower Panel.
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